Here, our findings suggested that MAPKAPK2 mRNA and protein levels are both significantly elevated in glioma especially GBM and MAPKAPK2 is positively correlated with poor prognosis of glioma patients. Here, MAPKAPK2 is linked to central nervous system cancer.